THE BLUE BOX: A NEW AGE FOR BREAST CANCER DIAGNOSTICS

Funder	European Commission
Recipient Organization	The Blue Box Biomedical Solutions Sl
Country	Spain
Start Date	Jun 01, 2022
End Date	May 31, 2023
Duration	364 days
Number of Grantees	1
Roles	Coordinator
Data Source	European Commission
Grant ID	`101071517`

Grant Description

THE BLUE BOX BIOMEDICAL SOLUTIONS S.L. is a deep tech European start-up developing a medical device based on Artificial Intelligence, capable of detecting breast cancer using urine samples, with 95% accuracy.

The Blue Box presents higher performance and safety features as compared to competing technologies (mammography, MRI and gene testing): It is NON-INVASIVE unlike mammography, as it uses urine samples, NON-IRRADIATING unlike mammography that makes use of radioactive materials, USER FRIENDLY as anyone can perform the test, LOW COST (